Forum for Injection Techniques (FIT India) in association with BD (Becton, Dickinson and Company), launched the first Indian clinical recommendations for best practices in insulin injection techniques.
A scientific advisory board of well-known endocrinologists and diabetes experts led the FIT India guidelines based on a combination of clinical evidence, the implications for patient therapy and the judgment of the group of experts. Although insulin therapy is accepted as one of the most effective and dependable treatment options in management of diabetes, there are several barriers to its usage among type 2 diabetes cases particularly acceptance of insulin therapy.
Dr. Sanjay Kalra, Department of Endocrinology, Bharti Hospital, Karnal and chief author of the recommendations (member, FIT India Advisory Board) said “These guidelines emphasize the need for appropriate injection technique that is crucial for the success of insulin therapy. I am happy to be a part of the FIT India guidelines advisory board as my work will enhance both the duration and quality of life of people living with diabetes.”
Traditionally, there has been a psychological resistance to initiation of insulin therapy in India. Insulin is the main injectable therapy used by people with diabetes and is designed using high levels of technology to finely tune its peak and duration of action which is precisely timed. However, if the technique used for injection is flawed, the way in which the insulin works and will affect the patient’s glycemic control is directly impacted.
Several factors, including the method of administration, dosing, compliance, selection of injection site, depth of the injection, time lapse before withdrawing the needle and misconceptions about insulin therapy, influence the success of insulin injection therapy.